Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
- Lancet Oncol., Volume 19, Issue 11, November 2018, Pages 1468-1479 | https://doi.org/10.1016/S1470-2045(18)30673-9